ReleaseWire Connect

Software-defined networking uses are beginning to emerge that show how the technology has resulted in cost efficiency and network flexibility in both enterprise and service provider environments. In the coming years, SDN's landscape would mature and encourage decision-makers around the world to embrace the future of IT infrastructure as the SDN industry is anticipated to bring about visible savings in capital expenditure as well as operating expenses. Driven by impact of the above, the market is expected to grow at a CAGR of around 62% during forecast period 2014-2018.

The sooner one finds out whether a food product is meeting quality and safety requirements or not, the sooner it can be sold. So time is a crucial factor here. Traditional methods take four days or more to complete the entire food testing procedure. This is where rapid testing methods are gaining huge popularity in the market.

Global semiconductor market is expected to experience a steady growth driven mainly by the increasing the sales of smart phones, tablets and communication devices. Massive growth demand for camera enabled low cost mobile phones and tablets across the globe accelerated the market as these applications mainly use CMOS image sensors due to their lower power consumption, smaller size, and faster speeds from parallel readout and processing. This will encourage the global semiconductor market in coming years.

The propelling capabilities of QLED have to provide brighter display at affordable cost and longer life has attracted many eyes from the industry. The industry will see more of QLED's in days to come because to its capabilities, which outperforms the current technologies. The market will be driven by QLED's and related innovations, simultaneously increasing high customer experience and better quality. This is one of the factors that support the anticipation of Global Nanoparticle market growing at a CAGR of around 16.7 % during the forecast period 2015-2020.

The market for non-invasive prenatal diagnostics tests in the US is currently dominated by Sequenom as it got the first mover advantage in the industry. With around 50% market share in terms of volume, Sequenom boasts of having effective marketing strategies that seek to encourage US physicians to recommend its MaterniT21 plus test. In terms of value, Sequenom will remain the market leader in 2018 as well accounting for over 45% of the total market share.

Following the advancements in insulin delivery devices, there have been ample attempts by the researchers to develop nanoparticles, protein molecules, absorption enhancers, etc. which can effectively release insulin at an appropriate site. Recently, a research team from Galgotias University, India, has discovered other forms of proteins molecules known as Emispheres for the delivery of insulin. These molecules are developed by condensation of different types of polymers. On reaching at an appropriate site, complex of emisphere-drug –transporters is dissociated, releasing drug in biologically active form.

According to a new research report by RNCOS entitled, "Brazil Pharmaceutical Market Outlook 2018", the Pharmaceutical industry of Brazil is a conglomerate market of domestic and international companies. As long as leading pharmaceutical players have been grappled with expiring patents and pricing pressures in developed markets, they are starting to expect more from emerging markets like Brazil. As in Brazil, the Ministry of Health is encouraging local manufacturers with reduced drug prices policies, increasing research and development; and boosting generics development. Among all the players competing in the domestic pharmaceutical market, foreign players such as Sanofi, Novartis, Merck, Roche, GSK and local companies such as Ache Laboratories, Hypermarcas, Eurofarma; EMS Pharma has emerged as a leader in the Brazilian Pharmaceutical Market.

India is currently the largest producer of milk in the world and is self-sufficient. India is going through winds of change on account of meliorated milk availability, globalization, and the entry of the private sector in the dairy industry. According to the recent report by RNCOS, traditional products claim a significant share in the dairy industry revenues; although these products have limited shelf-life. Now with the advent of novel milk processing technologies, the sector is poised to gear up.

The burden of chronic diseases has been tremendously increasing across the globe which ultimately strains the economic growth of a country. The rapidly spreading chronic diseases and ageing population demand high end technological devices that have resulted in a global telemedicine market worth US$ 14.2 Billion in 2012. Besides, the shortage of physicians in rural areas has also advanced the telemedicine market to gain widespread adoption.

According to a new research report by RNCOS entitled, "Global Antibody Drug Conjugate Market Outlook 2018", CDX-011 is a fully human monoclonal antibody drug conjugate targeting glycoprotein non-metastatic b (GPNMB) protein. GPNMB is expressed by multiple tumor types including breast cancer and melanoma. This antibody candidate is linked to potent cytotoxic monomethyl auristatin E using Seattle's genetic proprietary technology. In 2013, Celldex Therapeutics launched a METRIC study of CDX-011 in patients with metastatic triple negative breast cancer with over expressed glycoprotein NMB. The aim of the study was to investigate the safety of CDX-011 in patients having advanced triple negative breast cancer in Phase II. The study was successful in overcoming breast cancer.